Back to Results
First PageMeta Content
Medicine / Intel Viiv / Integrase / ViiV Healthcare / Shionogi / New Drug Application / HIV / Food and Drug Administration / Dolutegravir / Integrase inhibitors / Pharmaceutical sciences / Biology


Document Date: 2014-11-03 11:26:18

Open Document

File Size: 26,08 KB

Share Result on Facebook

City

Osaka / London / /

Company

ViiV Healthcare / Shionogi-ViiV Healthcare LLC / Shionogi & Co. Ltd. / Corporate Communications Shionogi & Co. Ltd. / /

Country

Japan / United States / Canada / /

Event

Business Partnership / FDA Phase / /

/

IndustryTerm

treatment of HIV / foreign healthcare reforms / with respect to product / /

MedicalCondition

HIV infection / HIV / /

Organization

European Union / European Medicines Agency / U.S. Food and Drug Administration / /

Person

Isao Teshirogi / Dominique Limet / /

/

Position

President & CEO / Chief Executive Officer / /

Product

Integrase Inhibitor / US / /

SocialTag